A postmarket safety comparison of 2 vaccination strategies for measles, mumps, rubella and varicella in Italy

References

• Klein NP, Lewis E, Fireman B, Hambidge SJ, Naleway A, Nelson JC, Belongia EA, Yih WK, Nordin JD, Hechter RC, et al; Safety of measles-containing vaccines in 1-year-old children. Pediatrics 2015; 135(2):321-9; http://dx.doi.org/10.1542/peds.2014-1822
   PubMed Web of Science ®Google Scholar
• Barlow WE, Davis RL, Glasser JW, Rhodes PH, Thompson RS, Mullooly JP, Black SB, Shinefield HR, Ward JI, Marcy SM, et al; Centers for Disease Control and Prevention Vaccine Safety Datalink Working Group. The risk of seizures after receipt of whole-cell pertussis or measles, mumps, and rubella vaccine. N Engl J Med 2001; 345(9):656-61; PMID:11547719; http://dx.doi.org/10.1056/NEJMoa003077
   PubMed Web of Science ®Google Scholar
• Griffin MR, Ray WA, Mortimer EA, Fenichel GM, Schaffner W. Risk of seizures after measles-mumps-rubella immunization. Pediatrics 1991; 88(5):881-5; PMID:1945626
   PubMed Web of Science ®Google Scholar
• Vestergaard M, Hviid A, Madsen KM, Wohlfahrt J, Thorsen P, Schendel D, Melbye M, Olsen J. MMR vaccination and febrile seizures: evaluation of susceptible subgroups and long-term prognosis. JAMA 2004; 292(3):351-7; PMID:15265850; http://dx.doi.org/10.1001/jama.292.3.351
   PubMed Web of Science ®Google Scholar
• Shinefield H, Black S, Digilio L, Reisinger K, Blatter M, Gress JO, Brown ML, Eves KA, Klopfer SO, Schödel F, et al. Evaluation of a quadrivalent measles, mumps, rubella and varicella vaccine in healthy children. Pediatr Infect Dis J 2005; 24(8):665-9; PMID:16094217; http://dx.doi.org/10.1097/01.inf.0000172902.25009.a1
   PubMed Web of Science ®Google Scholar
• Marin M1, Broder KR, Temte JL, Snider DE, Seward JF; Centers for Disease Control and Prevention (CDC). Use of combination measles, mumps, rubella, and varicella vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2010; 59(RR-3):1-12; PMID:20448530
   PubMedGoogle Scholar
• Centers for Disease Control and Prevention. Prevention of varicella: recommendations of the advisory committee on immunization practices (ACIP). Centers for Disease Control and Prevention. MMWR Recomm Rep 1996; 45:1-36
   Google Scholar
• Baldo V, Baldovin T, Russo F, Busana MC, Piovesan C, Bordignon G, Giliberti A, Trivello R. Varicella: epidemiological aspects and vaccination coverage in the Veneto Region. BMC Infect Dis 2009; 150:2334-9; PMID:19116339
   PubMed Web of Science ®Google Scholar
• Baldo V, Ferro A, Napoletano G, Milani S, Bertoncello L, Baldovin T, Trivello R. Universal varicella vaccination in the Veneto Region, Italy: launch of a programme targeting all children aged 14 months and susceptible adolescents. Euro Surveill 2007; 12:E071101.3; PMID:17997908
   PubMedGoogle Scholar
• Bechini A, Boccalini S, Baldo V, Cocchio S, Castiglia P, Gallo T, Giuffrida S, Locuratolo F, Tafuri S, Martinelli D, et al. Impact of universal vaccination against varicella in Italy. Hum Vaccin Immunother 2015; 11:63-71; PMID:25483517; http://dx.doi.org/10.4161/hv.34311
   PubMed Web of Science ®Google Scholar
• Schink T, Holstiege J, Kowalzik F, Zepp F, Garbe E. Risk of febrile convulsions after MMRV vaccination in comparison to MMR or MMR+V vaccination. Vaccine 2014; 32:645-50; PMID:24374498; http://dx.doi.org/10.1016/j.vaccine.2013.12.011
   PubMed Web of Science ®Google Scholar
• Jacobsen SJ, Ackerson BK, Sy LS, Tran TN, Jones TL, Yao JF, Xie F, Cheetham TC, Saddier P. Observational safety study of febrile convulsion following first dose MMRV vaccination in a managed care setting. Vaccine 2009; 27:4656-61; PMID:19520201; http://dx.doi.org/10.1016/j.vaccine.2009.05.056
   PubMed Web of Science ®Google Scholar
• Ma SJ, Xiong YQ, Jiang LN, Chen Q. Risk of febrile seizure after measles-mumps-rubella-varicella vaccine: A systematic review and meta-analysis. Vaccine 2015; 33(31):3636-49; http://dx.doi.org/10.1016/j.vaccine.2015.06.009.
   PubMed Web of Science ®Google Scholar
• Approvazione Nuovo “Calendario Vaccinale della Regione del Veneto”. Delibera della giunta regionale n. 1564 del 26/08/2014. Bollettino ufficiale della Regione Veneto 2014; n.89 del 12/09/2014.
   Google Scholar
• Ministero della Salute. Nuovo modello di segnalazione di reazione avversa a farmaci e vaccini. Decreto ministeriale del 2.12. 2003. Gazzetta Ufficiale della Repubblica Italiana 2004; 36:8-15
   Google Scholar
• Zanoni G, Nguyen TM, Valsecchi M, Gallo G, Tridente G. Prevention and monitoring of adverse events following immunization: the “Green Channel” of the Veneto region in Italy. Vaccine 2003 22:194-201; PMID:14615146; http://dx.doi.org/10.1016/S0264-410X(03)00566-8
   PubMed Web of Science ®Google Scholar
• Micheletti F, Moretti U, Tridente G, Zanoni G. Consultancy and surveillance of post-immunisation adverse events in the Veneto region of Italy for 1992-2008. Human Vaccines 2011; 7:234-239; PMID:21301223; http://dx.doi.org/10.4161/hv.7.0.14613
   PubMed Web of Science ®Google Scholar
• Garante per la protezione dei dati personali. Autorizzazione generale al trattamento dei dati personali effettuato per scopi di ricerca scientifica - 1° marzo 2012. Gazzetta Ufficiale della Repubblica Italiana 2012; 72:47-52
   Google Scholar
• Codice in materia di protezione dei dati personali, Decreto Legislativo 30 giugno 2003, n. 196. Gazzetta Ufficiale della Repubblica Italiana 2003; 174 (S.O. 123):1-208
   Google Scholar
• Da Re F, Russo F, Verizzi E. Report sull'attività vaccinale dell'anno 2013, copertura vaccinale a 24 mesi (coorte 2011) ; internet. Regione Veneto, Settore Promozione e sviluppo Igiene e sanità pubblica. 2014 July 30; update 2015, Feb 12; cited 2015 Sep 04. Available at http://www.regione.veneto.it/web/sanita/monitoraggio-vaccinazioni.
   Google Scholar
• Ministero della Salute. Piano nazionale prevenzione vaccinale 2012-2014; internet. Roma, 2014 November 13; update 2015, February 5; cited 2015 September 04 Availableat http://www.salute.gov.it/imgs/C_17_pubblicazioni_1721_allegato.pdf.
   Google Scholar
• Ministero della Salute. Sintesi delle coperture vaccinali in età pediatrica 2000-2013 ; internet. Roma, 2014 August 28; update 2015, August 28; cited 2015 September 04 Availableat http://www.salute.gov.it/portale/documentazione/p6_2_8_3_1.jsp?lingua=italiano&id=20
   Google Scholar
• Dodd D. Benefits of combination vaccines: effective vaccination on a simplified schedule. Am J Manag Care 2003; 9:S6-12; PMID:12564784
   PubMed Web of Science ®Google Scholar
• Leung JH, Hirai HW, Tsoi KK. Immunogenicity and reactogenicity of tetravalent vaccine for measles, mumps, rubella and varicella (MMRV) in healthy children: a meta-analysis of randomized controlled trials. Expert Review of Vaccines 2015; 14:1149-57); PMID:26081133; http://dx.doi.org/10.1586/14760584.2015.1057572
   PubMed Web of Science ®Google Scholar
• Streng A, Liese JG. Decline of varicella vaccination in German surveillance regions after recommendation of separate first-dose vaccination for varicella and measles-mumps-rubella. Vaccine 2014; 32:897-900; PMID:24412300; http://dx.doi.org/10.1016/j.vaccine.2013.12.065
   PubMed Web of Science ®Google Scholar